The recently FDA-authorized Pfizer-BioNTech COVID-19 vaccine is not contraindicated for people living with HIV or others with immunocompromised conditions, though vaccine efficacy data does not currently exist for potentially immunocompromised individuals. According to the CDC Advisory Committee on Immunization Practices (ACIP), people living with HIV may still receive the vaccine, but should be counseled on unknown vaccine safety and efficacy profiles in immunocompromised persons.
Read more about clinical considerations for the Pfizer-BioNTech vaccine in the new Morbidity and Mortality Weekly Report (MMWR): The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine — United States, December 2020. Information specific to people living with HIV can be found on slide 14 of this presentation from ACIP.
Updated information will be posted to our blog as it becomes available.